FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2801351505> ?p ?o ?g. }

• W2801351505 endingPage "179" @default.
• W2801351505 startingPage "172" @default.
• W2801351505 abstract "The infliximab biosimilar has entered daily inflammatory bowel disease (IBD) practice. However, real-life outcomes beyond 1 year after switching are scarce. We aimed to investigate the long-term drug survival, immunogenicity, and pharmacokinetics 2 years after switching to CT-P13 in IBD patients. We performed a single-center prospective observational cohort study in all Remicade-treated IBD patients who previously switched to CT-P13. We systematically documented reasons for discontinuation, trough levels, and antidrug antibodies to infliximab (ADAs) at baseline, week 16, week 52, and week 104. Clinical and biochemical disease activity (HBI, SCCAI, CRP) and adverse events were registered. Eighty-three patients were enrolled, 57 had Crohn’s disease, 24 had ulcerative colitis, and 2 were IBD-unclassified. At week 104, 55 of 83 (66%) patients remained on CT-P13, and 3 were lost to follow-up. Reasons for discontinuation were loss of response (n = 10), adverse events (n = 8), and disease remission (n = 7). ADAs were present in 5/83 patients at baseline (before switching), in 2 patients before week 52, and no subsequent ADAs were detected until week 104. Median trough levels and clinical and biochemical disease activity at baseline, week 16, week 52 and week 104 did not significantly change. In a prospective cohort with >2-year follow-up, 66% of IBD patients continued CT-P13 after switching from Remicade. Two new cases with ADAs were observed in year 1, but subsequently no immunogenicity was detected. These results are reassuring and suggest that switching to CT-P13 does not impact long-term clinical outcomes." @default.
• W2801351505 created "2018-05-17" @default.
• W2801351505 creator A5013205632 @default.
• W2801351505 creator A5033556021 @default.
• W2801351505 creator A5051118974 @default.
• W2801351505 creator A5072837175 @default.
• W2801351505 creator A5078377172 @default.
• W2801351505 creator A5082888669 @default.
• W2801351505 creator A5091141688 @default.
• W2801351505 date "2018-06-27" @default.
• W2801351505 modified "2023-09-27" @default.
• W2801351505 title "Drug Survival and Immunogenicity After Switching From Remicade to Biosimilar CT-P13 in Inflammatory Bowel Disease Patients: Two-year Follow-up of a Prospective Observational Cohort Study" @default.
• W2801351505 cites W1989693988 @default.
• W2801351505 cites W1997999969 @default.
• W2801351505 cites W2003314961 @default.
• W2801351505 cites W2003835888 @default.
• W2801351505 cites W2006396734 @default.
• W2801351505 cites W2008365376 @default.
• W2801351505 cites W2017883234 @default.
• W2801351505 cites W2034008046 @default.
• W2801351505 cites W2072640801 @default.
• W2801351505 cites W2113674146 @default.
• W2801351505 cites W2117212747 @default.
• W2801351505 cites W2121050884 @default.
• W2801351505 cites W2148487286 @default.
• W2801351505 cites W2153438195 @default.
• W2801351505 cites W2162768160 @default.
• W2801351505 cites W2169467558 @default.
• W2801351505 cites W2259088801 @default.
• W2801351505 cites W2314763045 @default.
• W2801351505 cites W2340152881 @default.
• W2801351505 cites W2342216265 @default.
• W2801351505 cites W2516607409 @default.
• W2801351505 cites W2560455300 @default.
• W2801351505 cites W2564912185 @default.
• W2801351505 cites W2578994901 @default.
• W2801351505 cites W2589358629 @default.
• W2801351505 cites W2599446307 @default.
• W2801351505 cites W2613299853 @default.
• W2801351505 cites W2624671969 @default.
• W2801351505 cites W2733544055 @default.
• W2801351505 cites W2771401588 @default.
• W2801351505 cites W2774116866 @default.
• W2801351505 cites W2794339583 @default.
• W2801351505 cites W2795103548 @default.
• W2801351505 doi "https://doi.org/10.1093/ibd/izy227" @default.
• W2801351505 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29947795" @default.
• W2801351505 hasPublicationYear "2018" @default.
• W2801351505 type Work @default.
• W2801351505 sameAs 2801351505 @default.
• W2801351505 citedByCount "21" @default.
• W2801351505 countsByYear W28013515052019 @default.
• W2801351505 countsByYear W28013515052020 @default.
• W2801351505 countsByYear W28013515052021 @default.
• W2801351505 countsByYear W28013515052022 @default.
• W2801351505 crossrefType "journal-article" @default.
• W2801351505 hasAuthorship W2801351505A5013205632 @default.
• W2801351505 hasAuthorship W2801351505A5033556021 @default.
• W2801351505 hasAuthorship W2801351505A5051118974 @default.
• W2801351505 hasAuthorship W2801351505A5072837175 @default.
• W2801351505 hasAuthorship W2801351505A5078377172 @default.
• W2801351505 hasAuthorship W2801351505A5082888669 @default.
• W2801351505 hasAuthorship W2801351505A5091141688 @default.
• W2801351505 hasConcept C121608353 @default.
• W2801351505 hasConcept C126322002 @default.
• W2801351505 hasConcept C188816634 @default.
• W2801351505 hasConcept C197934379 @default.
• W2801351505 hasConcept C201903717 @default.
• W2801351505 hasConcept C23131810 @default.
• W2801351505 hasConcept C2777044582 @default.
• W2801351505 hasConcept C2777138892 @default.
• W2801351505 hasConcept C2778260677 @default.
• W2801351505 hasConcept C2778435480 @default.
• W2801351505 hasConcept C2778715236 @default.
• W2801351505 hasConcept C2779134260 @default.
• W2801351505 hasConcept C2779280984 @default.
• W2801351505 hasConcept C2780479503 @default.
• W2801351505 hasConcept C2909675724 @default.
• W2801351505 hasConcept C2911091166 @default.
• W2801351505 hasConcept C31785415 @default.
• W2801351505 hasConcept C526805850 @default.
• W2801351505 hasConcept C59491497 @default.
• W2801351505 hasConcept C71924100 @default.
• W2801351505 hasConcept C72563966 @default.
• W2801351505 hasConcept C90924648 @default.
• W2801351505 hasConceptScore W2801351505C121608353 @default.
• W2801351505 hasConceptScore W2801351505C126322002 @default.
• W2801351505 hasConceptScore W2801351505C188816634 @default.
• W2801351505 hasConceptScore W2801351505C197934379 @default.
• W2801351505 hasConceptScore W2801351505C201903717 @default.
• W2801351505 hasConceptScore W2801351505C23131810 @default.
• W2801351505 hasConceptScore W2801351505C2777044582 @default.
• W2801351505 hasConceptScore W2801351505C2777138892 @default.
• W2801351505 hasConceptScore W2801351505C2778260677 @default.
• W2801351505 hasConceptScore W2801351505C2778435480 @default.
• W2801351505 hasConceptScore W2801351505C2778715236 @default.
• W2801351505 hasConceptScore W2801351505C2779134260 @default.
• W2801351505 hasConceptScore W2801351505C2779280984 @default.

• next